ATE336230T1 - Orale pharmazeutische zusammensetzung und verfahren zu ihrer herstellung - Google Patents

Orale pharmazeutische zusammensetzung und verfahren zu ihrer herstellung

Info

Publication number
ATE336230T1
ATE336230T1 AT04003906T AT04003906T ATE336230T1 AT E336230 T1 ATE336230 T1 AT E336230T1 AT 04003906 T AT04003906 T AT 04003906T AT 04003906 T AT04003906 T AT 04003906T AT E336230 T1 ATE336230 T1 AT E336230T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
production
oral pharmaceutical
composition
bet
Prior art date
Application number
AT04003906T
Other languages
English (en)
Inventor
Claudia Dr Mattern
Wilfried Pieper
Original Assignee
Mattern Udo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mattern Udo filed Critical Mattern Udo
Application granted granted Critical
Publication of ATE336230T1 publication Critical patent/ATE336230T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT04003906T 2004-02-20 2004-02-20 Orale pharmazeutische zusammensetzung und verfahren zu ihrer herstellung ATE336230T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04003906A EP1566173B1 (de) 2004-02-20 2004-02-20 Orale pharmazeutische Zusammensetzung und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE336230T1 true ATE336230T1 (de) 2006-09-15

Family

ID=34707350

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04003906T ATE336230T1 (de) 2004-02-20 2004-02-20 Orale pharmazeutische zusammensetzung und verfahren zu ihrer herstellung

Country Status (16)

Country Link
US (1) US7767228B2 (de)
EP (2) EP1566173B1 (de)
JP (1) JP4800225B2 (de)
AT (1) ATE336230T1 (de)
AU (1) AU2005215108B2 (de)
BR (1) BRPI0507848A (de)
CA (1) CA2554640C (de)
DE (1) DE602004001969T2 (de)
DK (1) DK1566173T3 (de)
ES (1) ES2271714T3 (de)
NO (1) NO20064240L (de)
PT (1) PT1566173E (de)
RU (1) RU2342936C2 (de)
SI (1) SI1566173T1 (de)
WO (1) WO2005079759A2 (de)
ZA (1) ZA200606554B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101257892B (zh) * 2005-05-18 2013-01-02 达沃尔泰拉公司 吸附剂的结肠递送
US8048413B2 (en) * 2006-05-17 2011-11-01 Helene Huguet Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
UY31410A1 (es) * 2007-10-30 2009-05-29 Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado
JP2010106007A (ja) * 2008-08-14 2010-05-13 Sony Corp 薬剤徐放剤、吸着剤、機能性食品、マスク及び吸着シート
PE20120182A1 (es) * 2008-12-05 2012-02-24 Bayer Ip Gmbh Extruidos con sustancias activas con forma de agujas
HU231017B1 (hu) 2012-05-08 2019-11-28 LAVET Gyógyszeripari Kft. Praziquantel tartalmú ízfedett formulációk
RU2514056C2 (ru) * 2012-08-21 2014-04-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации Способ инкапсуляции фенбендазола
JP6472341B2 (ja) * 2015-06-26 2019-02-20 株式会社トーヨー技術研究所 固形状の魚類用経口投与薬剤、当該薬剤を含む養魚用飼料、および当該薬剤を魚に投与する方法
CA3191671A1 (en) 2020-09-04 2022-03-10 Elanco Us Inc. Palatable formulations
CN117881425A (zh) 2021-08-31 2024-04-12 株式会社东洋技术研究所 水栖动物用经口给药药剂
JP7368042B2 (ja) 2021-08-31 2023-10-24 株式会社トーヨー技術研究所 水棲動物用経口投与薬剤

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1879601A (en) * 1926-03-13 1932-09-27 Merck & Co Inc Iodine composition
BE634024A (de) * 1962-06-25
US3709833A (en) * 1970-08-21 1973-01-09 Owens Illinois Inc Process for preparing high purity silicon oxide porous beads doped with small quantities of other oxides
US4581232A (en) * 1983-07-20 1986-04-08 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates
SU1465052A1 (ru) * 1985-06-10 1989-03-15 Институт Зоологии Ан Казсср Способ профилактики и лечени гельминтозов животных
US5013716A (en) * 1988-10-28 1991-05-07 Warner-Lambert Company Unpleasant taste masking compositions and methods for preparing same
JPH05238930A (ja) * 1992-02-28 1993-09-17 Eisai Co Ltd 持続性薬剤
IL116674A (en) * 1995-01-09 2003-05-29 Mendell Co Inc Edward Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US5827497A (en) * 1996-08-14 1998-10-27 Mayo Foundation For Medical Education And Research Charcoal-radionuclide agents for measurement of gastrointestinal transit
WO1998053802A1 (en) * 1997-05-30 1998-12-03 Laboratorios Phoenix U.S.A., Inc. Multi-layered osmotic device
DE19726412A1 (de) * 1997-06-21 1998-12-24 Merck Patent Gmbh Implantatmaterial mit einer Träger-Wirkstoff-Kombination
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
JP3834732B2 (ja) * 1998-08-05 2006-10-18 株式会社ロッテ チューインガム
US6555139B2 (en) * 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
US6491949B2 (en) * 2000-01-14 2002-12-10 Osmotica Corp. Osmotic device within an osmotic device
EP1362583A1 (de) * 2002-05-15 2003-11-19 CUM Taste Masking AG Verfahren zur Geschmacksmaskierung von Substanzen durch Mikroverkapselung
US7001889B2 (en) * 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
KR101030735B1 (ko) * 2002-08-13 2011-04-26 인터벳 인터내셔널 비.브이. 첨가제를 전달하는 조성물 및 전달 방법
WO2004040679A1 (ja) * 2002-10-31 2004-05-13 Matsushita Electric Industrial Co., Ltd. 多孔電極およびそれを用いた電気化学素子

Also Published As

Publication number Publication date
NO20064240L (no) 2006-11-20
US20050186272A1 (en) 2005-08-25
CA2554640A1 (en) 2005-09-01
ZA200606554B (en) 2008-05-28
AU2005215108A1 (en) 2005-09-01
SI1566173T1 (sl) 2006-12-31
DE602004001969T2 (de) 2007-03-15
RU2006133543A (ru) 2008-04-10
AU2005215108B2 (en) 2010-10-07
CA2554640C (en) 2011-04-12
EP1566173A1 (de) 2005-08-24
JP4800225B2 (ja) 2011-10-26
ES2271714T3 (es) 2007-04-16
JP2007523108A (ja) 2007-08-16
DK1566173T3 (da) 2006-12-27
DE602004001969D1 (de) 2006-09-28
PT1566173E (pt) 2006-12-29
EP1715850A2 (de) 2006-11-02
WO2005079759A3 (en) 2006-06-15
BRPI0507848A (pt) 2007-07-10
US7767228B2 (en) 2010-08-03
RU2342936C2 (ru) 2009-01-10
EP1566173B1 (de) 2006-08-16
WO2005079759A2 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
NO20064240L (no) Farmasoytiske forbindelser for oral administrasjon og fremgangsmate for fremstilling derav
DE60100186D1 (de) Orale pharmazeutische formulierungen von benzimidazolderivaten und verfahren zu ihrer herstellung
WO2007098128A3 (en) Phenylephrine-containing liquid formulations
ATE514694T1 (de) 2-amino-7,8-dihydro-6h-pyrido(4,3-d)pyrimidin-5 one, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
MXPA04004464A (es) Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
BRPI0515684A (pt) formulações de cristais injetáveis ativas de longa duração de metabólitos de estradiol, e métodos de utilização das mesmas
EP1726299A3 (de) Kerne und Mikrokapsel zur parenteralen Verabreichung sowie Verfahren zu deren Herstellung
DE60142768D1 (de) 12CaO*7Al2O3 : EINE ZUSAMMENSETZUNG ZUR BILDUNG VORFAHREN ZUR HERSTELLUNG DERSELBEN
ATE471930T1 (de) 3-aminocarbazolverbindungen, pharmazeutische zusammensetzungen, die diese enthalten, und verfahren zu deren herstellung
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
ATE374172T1 (de) Hexensäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon
BRPI0620229B8 (pt) formulações farmaceuticas e processos de produção da ditas formulações
MX2008001560A (es) Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
CY1112960T1 (el) Παραγωγα ουριας, μεθοδοι για την παρασκευη τους και χρησεις αυτων
ES2328496T3 (es) Compuestos de 1,4,8-triaza-espiro(4,5)decan-2-ona sustituidos.
ATE528301T1 (de) Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen
ATE390138T1 (de) Dipyridamol enthaltende zusammensetzungen mit verlängerter freisetzung und verfahren zu deren herstellung
NO20071299L (no) Vedvarende frigivelse farmasoytisk sammensetning av tolterodine
DE60304599D1 (de) Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE503749T1 (de) Buttersäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon
AU2003230189A1 (en) Oral controlled release pharmaceutical composition containing metaxalone as active agent
DE50113943D1 (de) 4-alkoxy-cyclohexan-1-amino-carbonsäureester und verfahren zu ihrer herstellung
ATE222586T1 (de) Benzolsulfonamidderivate und verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE602005011888D1 (de) Verfahren zur Herstellung eines einbügelbaren Einlagestoffs, sowie dadurch hergestellter Einlagestoff
ATE370927T1 (de) Pentensäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und deren therapeutische anwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1566173

Country of ref document: EP